ELABS — Elliptic Laboratories ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK750.61m
- NOK710.43m
- NOK131.91m
- 59
- 20
- 14
- 17
Annual cashflow statement for Elliptic Laboratories ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | NAS | NAS | NAS | NAS | NAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.6 | -13.1 | -39.3 | -47 | 17 |
| Depreciation | |||||
| Non-Cash Items | 5.66 | 11 | 9.37 | 9.4 | 2.09 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.22 | -17 | 1.27 | -16.7 | -51.6 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.68 | -10.8 | -17.3 | -38.1 | -10.6 |
| Capital Expenditures | -15.1 | -17.6 | -23.3 | -25.6 | -30.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | 2.24 | 0.896 | 5.95 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -15.1 | -17.6 | -21.1 | -24.7 | -24.6 |
| Financing Cash Flow Items | -10.6 | -9.19 | 1.97 | -1.95 | -1.83 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 87.2 | 147 | -2.26 | -1.46 | -7.13 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 65.4 | 118 | -39.9 | -62.6 | -39.2 |